We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Formulatrix Announces Licensing Agreement
News

Formulatrix Announces Licensing Agreement

Formulatrix Announces Licensing Agreement
News

Formulatrix Announces Licensing Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Formulatrix Announces Licensing Agreement "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Formulatrix has announced that it has entered into a global licensing agreement with the research division of Novartis for Formulatrix' Rock Maker software.

Rock Maker will integrate Novartis' entire crystallization process including experimental design, liquid handling, imaging, and data management.

Jeremy Stevenson, President of Formulatrix stated, "This deal reinforces our belief that Rock Maker is the premier software solution for automating protein crystallization. This sale also provides us with additional resources to invest into the continued development of Rock Maker."

Formulatrix specializes in providing technology that automates the protein crystallization process, a key part of structure based drug discovery. visit

Advertisement